SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004144
Filing Date
2018-05-07
Accepted
2018-05-07 16:03:16
Documents
74
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20180331x10q.htm 10-Q 1150208
2 EX-31.1 nviv-20180331ex31129d02b.htm EX-31.1 15114
3 EX-31.2 nviv-20180331ex3129e150f.htm EX-31.2 15123
4 EX-32.1 nviv-20180331ex321c4239c.htm EX-32.1 8154
5 EX-32.2 nviv-20180331ex32265fd19.htm EX-32.2 8172
  Complete submission text file 0001558370-18-004144.txt   5263851

Data Files

Seq Description Document Type Size
6 EX-101.INS nviv-20180331.xml EX-101.INS 945954
7 EX-101.SCH nviv-20180331.xsd EX-101.SCH 42255
8 EX-101.CAL nviv-20180331_cal.xml EX-101.CAL 39211
9 EX-101.DEF nviv-20180331_def.xml EX-101.DEF 213209
10 EX-101.LAB nviv-20180331_lab.xml EX-101.LAB 445165
11 EX-101.PRE nviv-20180331_pre.xml EX-101.PRE 371961
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 18811223
SIC: 3841 Surgical & Medical Instruments & Apparatus